Despite the lower anti-FXa activity , dose reduction preserved the efficacy of edoxaban compared with warfarin ( stroke or systemic embolic event : higher dose pinteraction = @ , lower dose pinteraction = @ ) and provided even greater safety ( major bleeding : higher dose pinteraction @ , lower dose pinteraction = @ ) .